117 Diagnostic utility of molecular and imaging biomarkers 2 Figure 10. Estimated pooled test performance of BRAF mutation analysis – Bethesda IV Forest plots showing the estimated pooled sensitivity, specificity, positive and negative likelihood ratios with their corresponding 95% confidence intervals of BRAF mutation analysis in Bethesda IV thyroid nodules with available histopathological follow-up. CI, confidence interval; df, degrees of freedom; DLR positive, positive diagnostic likelihood ratio; DLR negative, negative diagnostic likelihood ratio; I2, heterogeneity statistic I2; Q, Cochran’s Q.
RkJQdWJsaXNoZXIy MTk4NDMw